0001179110-15-009972.txt : 20150617 0001179110-15-009972.hdr.sgml : 20150617 20150617171821 ACCESSION NUMBER: 0001179110-15-009972 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150615 FILED AS OF DATE: 20150617 DATE AS OF CHANGE: 20150617 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 6174983300 MAIL ADDRESS: STREET 1: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Holmes Scott A CENTRAL INDEX KEY: 0001537670 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10865 FILM NUMBER: 15937884 MAIL ADDRESS: STREET 1: C/O AMAG PHARMACEUTICALS, INC. STREET 2: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 edgar.xml FORM 4 - X0306 4 2015-06-15 0 0000792977 AMAG PHARMACEUTICALS INC. AMAG 0001537670 Holmes Scott A C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER STREET WALTHAM MA 02451 0 1 0 0 SVP, Finance and Treasurer Common Stock 2015-06-15 4 S 0 1346 66.63 D 51958 D Common Stock 2015-06-15 4 M 0 2734 14.89 A 54692 D Common Stock 2015-06-15 4 M 0 3500 16.55 A 58192 D Common Stock 2015-06-15 4 S 0 6234 66.63 D 51958 D Stock Option (Right to Buy) 14.89 2015-06-15 4 M 0 2734 0 A 2019-06-25 Common Stock 2734 14375 D Stock Option (Right to Buy) 16.55 2015-06-15 4 M 0 3500 0 A 2023-02-28 Common Stock 3500 11500 D The reported transactions on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 4, 2015. This option vests and becomes exercisable over four years from the grant date (June 25, 2012), with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal quarterly installments over the next three years thereafter. This option vests and becomes exercisable over four years from the grant date (February 28, 2013), with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal quarterly installments over the next three years thereafter. Nancy R. Smith, attorney-in-fact 2015-06-17